Attenuation of HIV-1 infection by other microbial agents
- PMID:16107952
- DOI: 10.1086/432767
Attenuation of HIV-1 infection by other microbial agents
Abstract
Although potentiation of human immunodeficiency virus (HIV) type 1 (HIV-1) infection has been known to occur in coinfection with a variety of pathogens and types of vaccination, there are emerging data on specific infectious agents that may attenuate HIV-1 infection. New literature suggests that certain pathogens are capable of inhibiting HIV-1 replication. These include GB virus C, measles virus, Orientia tsutsugamushi, and human T lymphotropic virus types 1 and 2. In addition, there are conflicting data on the effects of Mycobacterium tuberculosis on the replication of HIV-1, with some suggesting that this organism may inhibit HIV-1 replication. Also remaining controversial are the possible protective effects of HIV type 2 against HIV-1 infection. In this review, we summarize and critically discuss the body of emerging literature concerning infections that may have the ability to attenuate HIV-1 infection.
Similar articles
- Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.Casoli C, Pilotti E, Bertazzoni U.Casoli C, et al.AIDS Rev. 2007 Jul-Sep;9(3):140-9.AIDS Rev. 2007.PMID:17982939Review.
- HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.Brites C, Sampalo J, Oliveira A.Brites C, et al.AIDS Rev. 2009 Jan-Mar;11(1):8-16.AIDS Rev. 2009.PMID:19290030Review.
- Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.Bassani S, López M, Toro C, Jiménez V, Sempere JM, Soriano V, Benito JM.Bassani S, et al.Clin Infect Dis. 2007 Jan 1;44(1):105-10. doi: 10.1086/510076. Epub 2006 Nov 21.Clin Infect Dis. 2007.PMID:17143825
- Viral coinfections among African children infected with human immunodeficiency virus type 1.Chakraborty R, Rees G, Bourboulia D, Cross AM, Dixon JR, D'Agostino A, Musoke R, Boshoff C, Rowland-Jones SL, Klenerman P.Chakraborty R, et al.Clin Infect Dis. 2003 Apr 1;36(7):922-4. doi: 10.1086/368207. Epub 2003 Mar 19.Clin Infect Dis. 2003.PMID:12652394
- Neurological aspects of HIV/human T lymphotropic virus coinfection.Tulius Silva M, de Melo Espíndola O, Bezerra Leite AC, Araújo A.Tulius Silva M, et al.AIDS Rev. 2009 Apr-Jun;11(2):71-8.AIDS Rev. 2009.PMID:19529747Review.
Cited by
- Host factors influencing susceptibility to HIV infection and AIDS progression.Lama J, Planelles V.Lama J, et al.Retrovirology. 2007 Jul 25;4:52. doi: 10.1186/1742-4690-4-52.Retrovirology. 2007.PMID:17651505Free PMC article.Review.
- Is HIV-1 evolving to a less virulent form in humans?Ariën KK, Vanham G, Arts EJ.Ariën KK, et al.Nat Rev Microbiol. 2007 Feb;5(2):141-51. doi: 10.1038/nrmicro1594. Epub 2007 Jan 4.Nat Rev Microbiol. 2007.PMID:17203103Free PMC article.Review.
- Host genetics and HIV-1: the final phase?Fellay J, Shianna KV, Telenti A, Goldstein DB.Fellay J, et al.PLoS Pathog. 2010 Oct 14;6(10):e1001033. doi: 10.1371/journal.ppat.1001033.PLoS Pathog. 2010.PMID:20976252Free PMC article.Review.
- Natural Scrub Typhus Antibody Suppresses HIV CXCR4(X4) Viruses.Watt G, Kantipong P, Burnouf T, Shikuma C, Philpott S.Watt G, et al.Infect Dis Rep. 2013 May 15;5(1):e8. doi: 10.4081/idr.2013.e8. eCollection 2013 Jan 22.Infect Dis Rep. 2013.PMID:24470959Free PMC article.Review.
- Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.Srikantiah P, Wong JK, Liegler T, Walusimbi M, Mayanja-Kizza H, Kayanja HK, Mugerwa RD, Charlebois ED, Boom WH, Whalen CC, Havlir DV.Srikantiah P, et al.J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):458-60. doi: 10.1097/QAI.0b013e31817e9fb4.J Acquir Immune Defic Syndr. 2008.PMID:19011423Free PMC article.No abstract available.
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical